Noha A. Amin

The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury

Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad et al. · Biomedicine & Pharmacotherapy · 2022 · 85 citations · Full text

Life Sciences, Immunology, Pharmacology +17

BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats

Sameh Saber, Mahmoud E. Youssef, Hossam Sharaf et al. · Life Sciences · 2021 · 74 citations

Life Sciences, Immunology, Pathobiology +14

A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition

Sameh Saber, Eslam E. Abd El-Fattah, Galal Yahya et al. · Pharmaceuticals · 2021 · 70 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling

Rania M. Khalil, Ahmed Shata, Eman M. Abd El-Kader et al. · Toxicology and Applied Pharmacology · 2020 · 66 citations

Life Sciences, Cell Biology, Pharmacology +14

Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis

Mahmoud E. Youssef, Eslam E. Abd El-Fattah, Hanan Eissa et al. · Frontiers in Pharmacology · 2021 · 60 citations · Full text

Life Sciences, Immunology, Pharmacology +17